Contrasting DIAGNOS (OTCMKTS:DGNOF) & Priority Technology (NASDAQ:PRTH)

Priority Technology (NASDAQ:PRTH) and DIAGNOS (OTCMKTS:DGNOF) are both small-cap business services companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, risk and earnings.

Valuation and Earnings

This table compares Priority Technology and DIAGNOS”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Priority Technology	$932.95 million	0.51	$23.38 million	$0.53	11.05
DIAGNOS	$80,000.00	301.28	-$3.08 million	($0.04)	-5.85

Priority Technology has higher revenue and earnings than DIAGNOS. DIAGNOS is trading at a lower price-to-earnings ratio than Priority Technology, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current recommendations and price targets for Priority Technology and DIAGNOS, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Priority Technology	0	3	2	1	2.67
DIAGNOS	0	0	0	0	0.00

Priority Technology presently has a consensus target price of $8.50, indicating a potential upside of 45.20%. Given Priority Technology’s stronger consensus rating and higher possible upside, research analysts plainly believe Priority Technology is more favorable than DIAGNOS.

Risk & Volatility

Priority Technology has a beta of 1.85, indicating that its share price is 85% more volatile than the S&P 500. Comparatively, DIAGNOS has a beta of -0.02, indicating that its share price is 102% less volatile than the S&P 500.

Insider & Institutional Ownership

11.5% of Priority Technology shares are owned by institutional investors. 66.2% of Priority Technology shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Priority Technology and DIAGNOS’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Priority Technology	5.78%	-60.29%	4.35%
DIAGNOS	-5,964.91%	N/A	-159.83%

Summary

Priority Technology beats DIAGNOS on 13 of the 15 factors compared between the two stocks.

About Priority Technology

Priority Technology Holdings, Inc. operates as a payment technology company in the United States. The company operates through three segments: Small and Medium-Sized Businesses (SMB) Payments, Business-To-Business (B2B) Payments, and Enterprise Payments. It offers SMB payments processing solutions for B2C transactions through independent sales organizations, financial institutions, independent software vendors, and other referral partners through its MX product suite, which includes MX Connect and MX Merchant products, such as MX Insights, MX Storefront, MX Retail, MX Invoice, MX B2B and ACH.com, and others, which provides flexible and customizable set of business applications that helps to manage critical business work functions and revenue performance to resellers and merchant clients using core payment processing. The company also offers CPX, a platform that offers accounts payable automation solutions, including virtual card, purchase card, ACH +, dynamic discounting, or check. In addition, it provides curated managed services; payment-adjacent technologies to facilitate the acceptance of electronic payments from customers; and Plastiq payables management software, which helps businesses in improving cash flow with instant access to working capital. Further, the company offers embedded finance and BaaS solutions to enterprise customers to modernize legacy platforms and accelerate software partners' strategies to monetize payments; and managed services solutions that provide audience-specific programs for institutional partners and other third parties; and consulting and development solutions. It serves SMB, and enterprises, as well as distribution partners, including retail and wholesale independent sales organizations, financial institutions, and independent software vendors. The company was founded in 2005 and is headquartered in Alpharetta, Georgia.

About DIAGNOS

DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.